Chinese Journal of Antituberculosis ›› 2020, Vol. 42 ›› Issue (12): 1339-1342.doi: 10.3969/j.issn.1000-6621.2020.12.017
• Review Articles • Previous Articles Next Articles
TANG Yu-ting, SANG Ying-ying(), XIA Chao
Received:
2020-10-12
Online:
2020-12-10
Published:
2020-12-24
Contact:
SANG Ying-ying
E-mail:yin_serena@yeah.net
TANG Yu-ting, SANG Ying-ying, XIA Chao. Research progress on clinical application of traditional Chinese medicine appropriate technology in the treatment of tuberculosis[J]. Chinese Journal of Antituberculosis, 2020, 42(12): 1339-1342. doi: 10.3969/j.issn.1000-6621.2020.12.017
Add to citation manager EndNote|Ris|BibTeX
URL: https://www.zgflzz.cn/EN/10.3969/j.issn.1000-6621.2020.12.017
[1] | 杨丹, 王晶. 肺结核治疗结局影响因素研究进展. 世界最新医学信息文摘, 2019,19(20):80-81. doi: 10.19613/j.cnki.1671-3141.2019.20.037. |
[2] |
Furin J, Cox H, Pai M. Tuberculosis. Lancet, 2019,393(10181):1642-1656.doi: 10.1016/ S0140-6736(19)30308-3.
doi: 10.1016/S0140-6736(19)30308-3 URL pmid: 30904262 |
[3] | World Health Organization. Global tuberculosis report 2020. Geneva: World Health Organization, 2020. |
[4] | 刘二勇, 周林, 薛晓, 等. 利福平胶囊(Ⅱ)对肺结核治疗效果及安全性研究. 中国防痨杂志, 2020,42(10):1092-1099. doi: 10.3969/j.issn.1000-6621.2020.10.015. |
[5] | 徐青丽, 洪鲜, 屠江锋, 等. 综合性医院应用中医适宜技术如何解决"三关"问题. 中国中西医结合急救杂志, 2020,27(5):620-623.doi: 10.3969/j.issn.1008-9691.2020.05.026. |
[6] | 黎靖, 冷远洪. 中医适宜技术在医养结合养老模式中的应用现状研究. 国际感染病学(电子版), 2020,9(1):233-234. |
[7] | 李琤, 陆强峰, 张月萍, 等. 益气养阴活血方联合常规化疗干预复治肺结核临床观察. 四川中医, 2019,37(10):79-82. |
[8] | 朱凌凌, 段逸山, 高驰, 等. 肺痨病名源流考. 中华中医药杂志, 2018,33(7):2994-2999. |
[9] | 王冰. 黄帝内经·素问. 南宁: 广西科学技术出版社, 2016: 42-43. |
[10] | 周毅. 中成药辅助治疗肺结核并空洞疗效观察. 当代医学, 2020,26(1):88-90. doi: 10.3969/j.issn.1009-4393.2020.01.035. |
[11] | 冯秀莉, 曹延伦, 任欣欣, 等. 益气润肺汤联合黄芪注射液对耐药肺结核患者临床症状及机体免疫功能影响. 世界中西医结合杂志, 2019,14(10):1423-1426,1430. doi: 10.13935/j.cnki.sjzx.191024. |
[12] | 李志明, 俞珊, 王涛. 柴竹石膏汤对29例反复发热结核病并发其他感染患者的疗效分析. 中国防痨杂志, 2020,42(2):121-125. doi: 10.3969/j.issn.1000-6621.2020.02.008. |
[13] | 李婷婷, 刘欢庆, 杜巧盈. 中药治疗肺结核的用药规律及作用机制预测. 中国防痨杂志, 2020,42(10):1115-1120.doi: 10.3969/j.issn.1000-6621.2020.10.018. |
[14] | 许彦超, 刘亚南, 李吉磊, 等. 中医外治法治疗食管癌评述. 中医学报, 2020,35(8):1681-1684. doi: 10.16368/j.issn.1674-8999.2020.08.378. |
[15] | 代安娜. 艾灸温通的作用. 世界最新医学信息文摘, 2018,18(7):132. doi: 10.19613/j.cnki.1671-3141.2018.7.107. |
[16] | 赵秀玲, 党亚丽. 艾叶挥发油化学成分和药理作用研究进展. 天然产物研究与开发, 2019,31(12):2182-2188. doi: 10.16333/j.1001-6880.2019.12.023. |
[17] | 曾红萍, 陈新, 朱琪, 等. 艾灸疗法治疗肺结核的作用机制研究进展. 湖南中医杂志, 2019,35(8):178-180. doi: 10.16808/j.cnki.issn1003-7705.2019.08.075. |
[18] | 时翠林, 徐俊驰, 陈兴年, 等. 中医艾灸配合抗结核药物对肺结核患者的临床疗效及其对γ-干扰素水平的影响. 抗感染药学, 2017,14(8):1541-1543. doi: 10.13493/j.issn.1672-7878.2017.08.031. |
[19] | 王陈晋, 杨斌, 王建云. 电灸仪干预耐多药结核治疗临床疗效观察. 甘肃科技, 2015,31(14):126-129. doi: 10.3969/j.issn.1000-0952.2015.14.042. |
[20] | 黄志余. 中医古方配合艾灸治疗肺结核13例的疗效观察. 光明中医, 2015,30(6):1332-1334. doi: 10.3969/j.issn.1003-8914.2015.06.096. |
[21] | 李建业, 陈宪海. 中药穴位贴敷治疗COPD稳定期的研究进展. 世界最新医学信息文摘, 2018,18(3):137. doi: 10.19613/j.cnki.1671-3141.2018.03.109. |
[22] | 李娜, 张葆青, 牛峰海, 等. 中药穴位贴敷治疗小儿呼吸系统疾病的研究进展. 中华中医药杂志, 2019,34(11):5331-5333. |
[23] | 何晶莹, 马淑英, 陈笑文, 等. 针药结合治疗结节型颈淋巴结结核临床观察. 黑龙江中医药, 1994,(3):46-47. |
[24] | 邓红霞, 吴兵兵, 秦甜. 颈淋巴结结核中医外治法应用体会. 中医外治杂志, 2016,25(3):59-60. doi: 10.3969/j.issn.1006-978X.2016.03.036. |
[25] | 黄兰莹, 唐可, 高子平. 从手太阴肺经气虚论“阴虚则盗汗”. 世界最新医学信息文摘, 2019,19(76):239-240. doi: 10.19613/j.cnki.1671-3141.2019.76.132. |
[26] | 朱峰. 盗汗散贴敷神厥穴治疗盗汗疗效观察. 实用中医药杂志, 2018,34(3):373-374. doi: 10.3969/j.issn.1004-2814.2018.03.093. |
[27] | 寇龙威, 郭艳幸, 郭珈宜. 中医药治疗膝骨关节炎的研究进展. 中医药通报, 2019,18(6):71-73,67. doi: 10.14046/j.cnki.zyytb2002.2019.06.021. |
[28] | 吴敏敏. 低频脉冲电经皮给药治疗小儿肺炎疗效研究. 中国实用医药, 2019,14(35):160-161. doi: 10.14163/j.cnki.11-5547/r.2019.35.087. |
[29] | 杨寅, 孔晓华, 崔岩飞, 等. 中医定向透药法联合针灸治疗肺结核盗汗的疗效观察. 护理与康复, 2019,18(2):60-62. doi: 10.3969/j.issn.1671-9875.2019.02.018. |
[30] | 李杏慈, 刘桂英, 何志群, 等. 耳穴压豆联合中医情志护理在妇科围手术期的应用观察. 湖南中医杂志, 2020,36(10):101-103. doi: 10.16808/j.cnki.issn1003-7705.2020.10.044. |
[31] | 苗雨. 耳穴压豆护理技术在糖尿病中的应用进展. 实用临床护理学电子杂志, 2019,4(26):184-185. |
[32] | 周玲霞, 黄金鹏. 宣肺敛汗益气汤联合耳穴贴压对肺结核患者盗汗疗效评价. 中国农村卫生事业管理, 2017,37(10):1276-1277. doi: 10.3969/j.issn.1005-5916.2017.10.057. |
[33] | 余微微. 微波理疗联合系统康复运动干预在乳腺癌患者中的应用. 医疗装备, 2020,33(3):148-149. |
[34] | 吕明圣, 晏军. 理肺健脾活血利水法治疗悬饮一例. 环球中医药, 2018,11(10):1573-1574. doi: 10.3969/j.issn.1674-1749.2018.10.018. |
[35] | 马冬雪. 微波热疗肺腧治疗结核性胸膜炎的疗效观察. 世界最新医学信息文摘, 2015,15(100):43,42. doi: 10.3969/j.issn.1671-3141.2015.100.026. |
[36] | 吴晓玲. 用局部中草药微波热疗疗法辅助治疗结核性包裹性胸膜炎的效果探析. 当代医药论丛, 2016,14(17):141-142. |
[37] | 傅华君, 胡云根, 韩雷. 发散式体外冲击波联合海桐皮汤熏蒸钙化性冈上肌治疗急性期腱炎26例. 中国中医骨伤科杂志, 2020,28(2):69-71. doi: 10.3969/j.issn.1003-8914.2015.06.096. |
[38] | 赵彩虹, 高玉亭, 郝慧琴. 类风湿关节炎外治法研究进展. 世界中西医结合杂志, 2019,14(12):1760-1763. doi: 10.13935/j.cnki.sjzx.191233. |
[39] | 崔岩飞, 郎雅珍, 沈美琴, 等. 中药熏蒸辅助治疗饮停胸胁型悬饮病临床观察. 浙江中西医结合杂志, 2019,29(3):225-227. doi: 10.3969/j.issn.1005-4561.2019.03.018. |
[1] | Li Yuhong, Mei Jinzhou, Su Wei, Ruan Yunzhou, Liu Yushu, Zhao Yanlin, Liu Xiaoqiu. Analysis of the treatment outcomes and influencing factors of rifampicin-resistant pulmonary tuberculosis patients aged 65 and above in China from 2015 to 2021 [J]. Chinese Journal of Antituberculosis, 2025, 47(4): 408-415. |
[2] | Wu Xuan, Zhang Yanqiu, Xu Jiying, Meng Dan, Sun Dingyong. Analysis of factors influencing the treatment outcomes of patients with pulmonary tuberculosis and diabetes mellitus in Henan Province (2019—2023) [J]. Chinese Journal of Antituberculosis, 2025, 47(4): 425-431. |
[3] | An Yuan, Bai Yunlong, Zhao Qinglong, Ma Jianjun, Jiang Xue, Pan Yan, Gao Ying, Gao Zhihui. Analysis of treatment outcomes and influencing factors of patients with pulmonary tuberculosis complicated with diabetes mellitus in Jilin Province,2018—2022 [J]. Chinese Journal of Antituberculosis, 2025, 47(4): 432-438. |
[4] | Zhang Peize, Gao Qian, Deng Guofang. [18F]FDT-PET-CT technology that may bring revolutionary changes to tuberculosis clinical research [J]. Chinese Journal of Antituberculosis, 2025, 47(3): 262-265. |
[5] | Yang Haixia, Zhang Xiaoyan, Huang Yi, Li Qiu. Effective and safety of concurrent intensity-modulated radiotherapy and anti-tuberculosis chemotherapy in patients with active pulmonary tuberculosis comorbid with thoracic tumor [J]. Chinese Journal of Antituberculosis, 2025, 47(3): 312-321. |
[6] | Wang Dafu, Ma Xiaoxue, Wang Yun, Li Fudong, Rao Wen, Gong Tingting, Li Shijun, Li Jinlan. Analysis of risk factors for patient delay and adverse treatment outcomes among patients with pulmonary tuberculosis and diabetes mellitus in Guizhou Province, 2016—2023 [J]. Chinese Journal of Antituberculosis, 2025, 47(2): 201-209. |
[7] | You Chengdong, Zhu Ling, Li Peibo. Research progress on serum trace elements in the development and nutritional support of pulmonary tuberculosis patients [J]. Chinese Journal of Antituberculosis, 2025, 47(2): 218-223. |
[8] | Fu Ying, Xiong Yangyang, Fang Si, Li Chuanxiang, Guo Hongrong. The research progress on the relationship between serum albumin and its derivative biomarkers and chronic obstructive pulmonary disease [J]. Chinese Journal of Antituberculosis, 2025, 47(2): 231-236. |
[9] | Li Fudong, Ma Xiaoxue, Zhou Jian, Wang Dafu, Zhang Yueying, Gong Tingting, Rao Wen, Hong Feng, Li Shijun, Li Jinlan. Characteristics and treatment outcome analysis of MTB/HIV dual infection patients in Guizhou Province from 2018 to 2023 [J]. Chinese Journal of Antituberculosis, 2025, 47(1): 36-43. |
[10] | Shi Yilin, Gu Yan. Meta-analysis of the efficacy, adverse reactions, and fatality rate of glucocorticoid combined with anti-tuberculosis drugs in the treatment of tuberculous serositis [J]. Chinese Journal of Antituberculosis, 2025, 47(1): 77-86. |
[11] | Fan Jun, Wang Heng, Lan Tinglong, Dong Weijie, Tang Kai, Li Yuan, Yan Guangxuan, Xu Shangsheng, Kang Zhigang, Qin Shibing. Clinical characteristics and surgical outcomes of 12 cases of non-tuberculous mycobacterial spondylitis [J]. Chinese Journal of Antituberculosis, 2025, 47(1): 87-95. |
[12] | Ye Zhiteng, Ren Fei, Wang Hua, Yang Ming, Chen Yu, Chen Xiaohong, Wang Yun, Fan Lin. Treatment outcomes and influencing factors in elderly patients with multidrug/rifampicin-resistant pulmonary tuberculosis: a national multicenter, retrospective cohort study [J]. Chinese Journal of Antituberculosis, 2024, 46(9): 1023-1029. |
[13] | Huang Tao, Jian Huiyong, Wang Xinqi, Liu Nianqiang, Yipar Aihaiti, Wang Mingzhe, Jiayinati Jingesi, Wang Senlu. Analysis of influencing factors of treatment outcomes in patients with pulmonary tuberculosis complicated with diabetes mellitus in Xinjiang Uygur Autonomous Region [J]. Chinese Journal of Antituberculosis, 2024, 46(9): 1083-1088. |
[14] | Li Wenhan, Yang Jing, Li Chunhua. Research progress of artificial intelligence in pulmonary tuberculosis imaging diagnosis and drug resistance prediction [J]. Chinese Journal of Antituberculosis, 2024, 46(9): 1098-1103. |
[15] | Liu Siyuan, Cun Xinhua, Wu Lei, Bai Ping, Zhou Yi, Rao Tao, Chen Lin, Dou Jichen, Zhao Heng, Wang Yizhou. Application of individualized 3D printed artificial vertebral body replacement in reconstruction of complex tuberculosis-affected spine [J]. Chinese Journal of Antituberculosis, 2024, 46(8): 918-925. |
Viewed | ||||||
Full text |
|
|||||
Abstract |
|
|||||